FDA Approves Cimzia Label Update Essential for Childbearing Women with Inflammatory Diseases
News
The U.S. Food and Drug Administration (FDA) recently approved UCB’s request for a label update for Cimzia (certolizumab pegol) indicating low transfer levels of the medication from mother to child through ... Read more